Bio-sight Capital names Koji Miyata as CEO, replacing Masayuki Tani
- Bio-sight Capital named Koji Miyata as representative director, effective Aug. 20, 2026.
- Former CEO Masayuki Tani stepped down from the post.
- Executive director Nobuo Fukuda moved to an adviser role.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-sight Capital Inc published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now